Cellectis SA (CLLS)
3.45
+0.07
(+2.07%)
USD |
NASDAQ |
Apr 02, 12:48
Cellectis Research and Development Expense (TTM) : 75.00M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| DBV Technologies SA | 107.07M |
| EDAP TMS SA | 9.632M |
| Akari Therapeutics Plc | 2.820M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| Autolus Therapeutics Plc | 117.80M |